Table 3.

Adverse Events Associated With Erythropoietin Use^a

Adverse Event	Severity
Thromboembolic events	++
Increased risk of stroke	++
Increased risk of cardiovascular events	++
Hypertension	+
Increased risk of death	+++

Severity is scored as follows: +, mild to moderate; ++, potentially severe and life-threatening; +++, very severe.